当前位置: 首页 > 详情页

Hepatotoxicity evaluation of traditional Chinese medicines using a computational molecular model

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Beijing 302 Hosp, Clin Trial Ctr, 100 West Fourth Ring Middle Rd, Beijing 100039, Peoples R China; [2]Beijing 302 Hosp, Liver Failure Therapy & Res Ctr, 100 West Fourth Ring Middle Rd, Beijing 100039, Peoples R China; [3]Beijing 302 Hosp, Comp Technol Ctr, Beijing, Peoples R China; [4]Capital Med Univ, Beijing Anzhen Hosp, Emergency & Crit Care Ctr, 2 Anzhen Rd, Beijing 100029, Peoples R China
出处:
ISSN:

关键词: Traditional Chinese medicine liver toxicity quantitative structure-activity relationship

摘要:
Background: Liver injury caused by traditional Chinese medicines (TCMs) is reported from many countries around the world. TCM hepatotoxicity has attracted worldwide concerns.Objective: This study aims to develop a more applicable and optimal tool to evaluate TCM hepatotoxicity. Methods: A quantitative structure-activity relationship (QSAR) analysis was performed based on published data and U.S. Food and Drug Administration's Liver Toxicity Knowledge Base (LTKB). Results: Eleven herbal ingredients with proven liver toxicity in the literature were added into the dataset besides chemicals from LTKB. The finally generated QSAR model yielded a sensitivity of 83.8%, a specificity of 70.1%, and an accuracy of 80.2%. Among the externally tested 20 ingredients from TCMs, 14 hepatotoxic ingredients were all accurately identified by the QSAR model derived from the dataset containing natural hepatotoxins. Conclusions: Adding natural hepatotoxins into the dataset makes the QSAR model more applicable for TCM hepatotoxicity assessment, which provides a right direction in the methodology study for TCM safety evaluation. The generated QSAR model has the practical value to prioritize the hepatotoxicity risk of TCM compounds. Furthermore, an open-access international specialized database on TCM hepatotoxicity should be quickly established.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 3 区 医学
小类 | 2 区 毒理学
最新[2025]版:
大类 | 3 区 医学
小类 | 2 区 毒理学
JCR分区:
出版当年[2015]版:
Q2 TOXICOLOGY
最新[2023]版:
Q2 TOXICOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Beijing 302 Hosp, Clin Trial Ctr, 100 West Fourth Ring Middle Rd, Beijing 100039, Peoples R China; [2]Beijing 302 Hosp, Liver Failure Therapy & Res Ctr, 100 West Fourth Ring Middle Rd, Beijing 100039, Peoples R China;
通讯作者:
通讯机构: [1]Beijing 302 Hosp, Clin Trial Ctr, 100 West Fourth Ring Middle Rd, Beijing 100039, Peoples R China; [2]Beijing 302 Hosp, Liver Failure Therapy & Res Ctr, 100 West Fourth Ring Middle Rd, Beijing 100039, Peoples R China; [4]Capital Med Univ, Beijing Anzhen Hosp, Emergency & Crit Care Ctr, 2 Anzhen Rd, Beijing 100029, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17070 今日访问量:0 总访问量:919 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院